Malaria study: New antimalarial drug, tafenoquine, requires higher doses to achieve cure reliably

NewsDesk @bactiman63 A new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a report published in eLife. The study suggests that the current 300 mg adult dose of tafenoquine reduces recurrent vivax malaria infection by 70%, whereas increasing it to 450 [...]

The post Malaria study: New antimalarial drug, tafenoquine, requires higher doses to achieve cure reliably appeared first on Outbreak News Today.